ATE157870T1 - Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma - Google Patents

Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Info

Publication number
ATE157870T1
ATE157870T1 AT95100934T AT95100934T ATE157870T1 AT E157870 T1 ATE157870 T1 AT E157870T1 AT 95100934 T AT95100934 T AT 95100934T AT 95100934 T AT95100934 T AT 95100934T AT E157870 T1 ATE157870 T1 AT E157870T1
Authority
AT
Austria
Prior art keywords
optionally substituted
hydrogen
treatment
ophthalmic composition
benzoxathiepine
Prior art date
Application number
AT95100934T
Other languages
English (en)
Inventor
Takahiro Ogawa
Takaaki Deguchi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE157870T1 publication Critical patent/ATE157870T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT95100934T 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma ATE157870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP747094 1994-01-27

Publications (1)

Publication Number Publication Date
ATE157870T1 true ATE157870T1 (de) 1997-09-15

Family

ID=11666688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95100934T ATE157870T1 (de) 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Country Status (9)

Country Link
US (1) US5538974A (de)
EP (1) EP0667156B1 (de)
KR (1) KR950032169A (de)
CN (1) CN1116928A (de)
AT (1) ATE157870T1 (de)
CA (1) CA2141176A1 (de)
DE (1) DE69500660T2 (de)
ES (1) ES2106573T3 (de)
TW (1) TW316235B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
KR20010073153A (ko) 1998-09-18 2001-07-31 제임스 에이. 아노 녹내장 치료용의 세로토닌성 5ｈｔ2 작용제
JP2004538240A (ja) * 2000-03-31 2004-12-24 パーデュー・リサーチ・ファウンデーション ホスホラミデートおよびそのための方法
FR2822467B1 (fr) * 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
CA2469663A1 (en) * 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
WO2004009586A1 (en) * 2002-07-19 2004-01-29 Biovitrum Ab Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
KR20050033654A (ko) * 2002-08-30 2005-04-12 알콘, 인코퍼레이티드 치환된 5-크로만-5-일-에틸아민 화합물 및 녹내장의 치료용그의 용도
JP2006511556A (ja) * 2002-12-13 2006-04-06 アルコン，インコーポレイテッド 新規のベンゾピラン類似体及び緑内障の治療のためのそれらの使用
WO2005018608A1 (ja) * 2003-08-20 2005-03-03 Santen Pharmaceutical Co., Ltd. 微粒子テノン嚢下投与ドラッグデリバリーシステム
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
TW200520760A (en) * 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
US20050276867A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
US7425572B2 (en) * 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EP2095713A1 (de) * 2006-10-20 2009-09-02 Limited Liability Company "Mitotechnology" Zusammensetzung für die regeneration und stimulation des wachstums von pflanzen und für die anpassung von pflanzen an unterschiedliche stressfaktoren
EA200900582A1 (ru) 2006-10-20 2009-08-28 Общество С Ограниченной Ответственностью "Митотехнология" Фармацевтические композиции для профилактики и лечения глазных патологий
WO2008094061A1 (fr) * 2007-01-29 2008-08-07 Limited Liability Company 'mitotechnology' Compositions pharmaceutiques et cosmétiques servant à accélérer le processus de cicatrisation de plaies et autres lésions superficielles
WO2008094062A1 (fr) 2007-01-29 2008-08-07 Limited Liability Company 'mitotechnology' Compositions pharmaceutiques servant à la prévention et au traitement de maladies oncologiques
US8679557B2 (en) * 2007-02-27 2014-03-25 Sentiss Pharma Private Limited Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma
EA201000142A1 (ru) * 2007-04-11 2010-04-30 Общество С Ограниченной Ответственностью "Митотехнология" Композиция, замедляющая старение и увеличивающая продолжительность жизни организма, и ее применение
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
WO2010056145A1 (ru) 2008-11-12 2010-05-20 Общество С Ограниченной Ответственностью "Митотехнология" Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов
ES2527791T3 (es) * 2009-06-10 2015-01-29 Mitotech Sa Composición farmacéutica para su uso en oftalmología médica y veterinaria
AU2009355359B2 (en) 2009-11-13 2016-11-10 Mitotech S.A. Pharmaceutical substances on the basis of mitochondrially addressed antioxidants
AU2010365803B2 (en) 2010-12-20 2015-02-05 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
JP6448366B2 (ja) 2011-06-03 2019-01-09 ミトテック ソシエテ アノニム ミトコンドリアを標的とする抗酸化剤の経口製剤ならびにそれらの調製および使用
CN114767688A (zh) * 2019-09-04 2022-07-22 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
EP0229467A1 (de) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin-Derivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
EP0667156A1 (de) 1995-08-16
DE69500660T2 (de) 1998-02-26
DE69500660D1 (de) 1997-10-16
CN1116928A (zh) 1996-02-21
ES2106573T3 (es) 1997-11-01
TW316235B (de) 1997-09-21
EP0667156B1 (de) 1997-09-10
KR950032169A (ko) 1995-12-20
CA2141176A1 (en) 1995-07-28
US5538974A (en) 1996-07-23

Similar Documents

Publication Publication Date Title
DE69500660D1 (de) Ophthalmische Zusammensetzung enthaltend ein 1,5-Benzoxathiepin-Derivat zur Behandlung von Glaukoma
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
DE69716226T2 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
ATE112762T1 (de) Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
ATE161723T1 (de) Arzneimittel zur verwendung bei der behandlung von parkinsonismus
DE69326395T2 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE104965T1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
ATE168690T1 (de) Indolderivate, ihre salze und sie enthaltende arzneimittel zur behandlung von herzkrankheiten
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
FI944678A0 (fi) 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia
ATE122892T1 (de) Zusammensetzung gegen katarakt.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE120461T1 (de) Imidazolylpropylguanidinderivat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel.
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties